Following a prior train bombing in February that killed 28 British soldiers, #Zionist #terrorist group #LEHI again mined the #CairoHaifaTrain line near #Binyamina on #ThisDayInHistory in 1948, this time killing 40 Arab civilians & injuring another 60. No British troops were hurt.

OncoHost's New Study Bridges Serum and Plasma Proteomics for Enhanced Biomarker Discovery OncoHost's groundbreaking study highlights a new framework for integrating serum and plasma proteomic datasets, transforming biomarker research in oncology.

OncoHost's New Study Bridges Serum and Plasma Proteomics for Enhanced Biomarker Discovery #Israel #OncoHost #PROphet #Binyamina #Biomarker

OncoHost Recognized with BIG Innovation Award for Transformative Healthcare Solutions in 2026 OncoHost has received the 2026 BIG Innovation Award in the Health category, celebrating its pioneering work in precision medicine and clinical outcomes.

OncoHost Recognized with BIG Innovation Award for Transformative Healthcare Solutions in 2026 #Israel #OncoHost #PROphet #Health_Innovation #Binyamina

OncoHost Honored as Gold Winner at the 2025 Healthcare Merit Awards OncoHost has been recognized with a Gold Award at the 2025 Merit Awards for Healthcare due to its innovative proteomics platform, PROphet®.

OncoHost Honored as Gold Winner at the 2025 Healthcare Merit Awards #healthcare #Israel #OncoHost #PROphet #Binyamina

OncoHost Achieves Recognition for Innovation in Proteomics at Global BioTech Awards OncoHost, a pioneering tech firm, has been awarded 'Proteomics Innovation of the Year' by BioTech Breakthrough. This honor highlights their groundbreaking advancements in precision medicine and patient care.

OncoHost Achieves Recognition for Innovation in Proteomics at Global BioTech Awards #Israel #OncoHost #PROphet #Binyamina #BioTech_Awards

OncoHost Unveils Exciting Advances in Plasma Proteomics for NSCLC at ISLB 2025 OncoHost showcases two innovative studies on plasma proteomics for non-small cell lung cancer monitoring and prediction at ISLB 2025, highlighting a transformative approach.

OncoHost Unveils Exciting Advances in Plasma Proteomics for NSCLC at ISLB 2025 #Israel #OncoHost #NSCLC #Binyamina #PROphetNSCLC

OncoHost Earns Top Recognition as Precision Oncology Leader in 2025 OncoHost has been awarded as the premier precision oncology solution for 2025 by Life Sciences Review, highlighting its innovative approach to cancer treatment.

OncoHost Earns Top Recognition as Precision Oncology Leader in 2025 #Israel #OncoHost #PROphet #Precision_Oncology #Binyamina

OncoHost Achieves Gold Winner Status at 2025 Merit Awards for R&D Excellence OncoHost has been awarded the Gold Winner status in the 2025 Merit Awards for its significant advancements in precision medicine research and development, reflecting its innovative contributions to healthcare.

OncoHost Achieves Gold Winner Status at 2025 Merit Awards for R&D Excellence #Israel #OncoHost #PROphet #Merit_Awards #Binyamina

New Study Highlights Resistance Mechanisms in Immunotherapy for Lung Cancer Patients Discover groundbreaking insights from OncoHost's study on treatment resistance in lung cancer, utilizing proteomics and AI for personalized therapy.

New Study Highlights Resistance Mechanisms in Immunotherapy for Lung Cancer Patients #Israel #Immunotherapy #OncoHost #Lung_Cancer #Binyamina

OncoHost Secures €2.5 Million EIC Grant to Enhance Immunotherapy Precision in Oncology OncoHost, awarded a €2.5 million grant, is set to revolutionize precision oncology. The funding will help develop a new biomarker for predicting patient response to immunotherapy.

OncoHost Secures €2.5 Million EIC Grant to Enhance Immunotherapy Precision in Oncology #Israel #Immunotherapy #Precision_Medicine #OncoHost #Binyamina

OncoHost and Gustave Roussy Collaborate to Enhance Immunotherapy Safety This partnership aims to develop predictive markers for immune-related adverse events in patients receiving immunotherapy, improving patient safety and treatment outcomes.

OncoHost and Gustave Roussy Collaborate to Enhance Immunotherapy Safety #Israel #Immunotherapy #OncoHost #Binyamina #Gustave_Roussy

OncoHost Achieves Prestigious Recognition at the 2025 BIG Innovation Awards OncoHost has been awarded the 2025 BIG Innovation Award in Healthcare for its groundbreaking precision oncology solutions, including the PROphet® platform.

OncoHost Achieves Prestigious Recognition at the 2025 BIG Innovation Awards #healthcare #Israel #OncoHost #PROphet #Binyamina

How #ElonMusk "moderates" posts about #Hezbollah's kamikaze drone attack on the #Golani base outside #Binyamina.

#Hezobollah #drone attack #Golani base outside #Binyamina.
20241014 - X restricts comment on Israeli media about the fate Israeli general

Dutzende Verletzte bei Drohnenangriff in Israel Bei einem Drohnenangriff auf die israelische Stadt Binyamina sind nach Angaben des Rettungsdienstes Magen David Adom mindestens 40 Menschen verletzt worden. Vier der Verletzten schwebten demnach am So...

#Binyamina: Dutzende Verletzte bei Drohnenangriff in Israel www.puls24.at/news/politik... Laut jüngsten israelischen Medienberichten 67 Verletzte..

Man arrested on suspicion of threatening to murder Netanyahu Resident of #Binyamina allegedly wrote in Telegram group: 'I'm saying it now, on Saturday night I'm murdering Bibi' The post Man arrested on suspicion of threatening to murder Netanyahu appeared first on The Times of Israel.

Man arrested on suspicion of threatening to murder Netanyahu: Resident of #Binyamina allegedly wrote in Telegram group: 'I'm saying it now, on Saturday night I'm murdering Bibi'


The post Man arrested on suspicion of threatening to murder Netanyahu appeared first on The Times of Israel.